Beibei Zhang

5PUBLICATIONS
3CO-AUTHORS
Innate immunityNutrigenomics and personalised nutritionMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2024
Ultrasound-Activatable In Situ Vaccine for Enhanced Antigen Self- and Cross-Presentation to Overcome Cancer Immunotherapy Resistance.

Ge Chen, Yongchao Wang, Lianfeng Mo

|Jul 14, 2023
A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors.

Ruirui Zhang, Ruifang Li, Lan Zhang

|Apr 13, 2023
In Situ STING-Activating Nanovaccination with TIGIT Blockade for Enhanced Immunotherapy of Anti-PD-1-Resistant Tumors.

Beibei Zhang, Juan Zhang, Yaqiong Li

|Nov 13, 2020
An integrated microfluidics for assessing the anti-aging effect of caffeic acid phenethylester in Caenorhabditis elegans.

Beibei Zhang, Liping Zhuang, Duanping Sun

|Mar 19, 2019
Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer.

Beibei Zhang, Qi Liu, Mengyuan Liu

Pageof 1

Frequent Collaborators

1 joint publications

Zuanguang Chen

1 joint publications

Lianzhong Zhang

1 joint publications

Xueqin Wang